CVE-2014-2955
Raritan PX before 1.5.11 on DPXR20A-16 devices allows remote attackers to bypass authentication...
Raritan PX before 1.5.11 on DPXR20A-16 devices allows remote attackers to bypass authentication and execute arbitrary IPMI commands by using cipher suite 0 (aka cipher zero) and an arbitrary password.
Exploit likelihood
What each source reports
NVD Score used
10.0
Raritan PX before 1.5.11 on DPXR20A-16 devices allows remote attackers to bypass authentication and execute arbitrary IPMI commands by using cipher suite 0 (aka cipher zero) and an arbitrary password.
- Record
CVE-2014-2955- CVSS 2.0
- 10.0 High
AV:N/AC:L/Au:N/C:C/I:C/A:C - Weakness
- CWE-287
- Updated
- 2026-11-02
CVE List No score
Raritan PX before 1.5.11 on DPXR20A-16 devices allows remote attackers to bypass authentication and execute arbitrary IPMI commands by using cipher suite 0 (aka cipher zero) and an arbitrary password.
- Record
CVE-2014-2955- Updated
- 2026-11-02
EUVDEUVD-2014-2977 No score
Raritan PX before 1.5.11 on DPXR20A-16 devices allows remote attackers to bypass authentication and execute arbitrary IPMI commands by using cipher suite 0 (aka cipher zero) and an arbitrary password.
- Record
EUVD-2014-2977- Updated
- 2026-11-03
GitHub AdvisoriesGHSA-7x69-82vj-v63v No score
Raritan PX before 1.5.11 on DPXR20A-16 devices allows remote attackers to bypass authentication...
Raritan PX before 1.5.11 on DPXR20A-16 devices allows remote attackers to bypass authentication and execute arbitrary IPMI commands by using cipher suite 0 (aka cipher zero) and an arbitrary password.
- Record
GHSA-7x69-82vj-v63v- Weakness
- CWE-287
- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases | EUVD | |
| first indexed | CVE List, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2014-2955 is a high vulnerability (CVSS 10.0) in Raritan Dpxr20a-16, published July 14, 2014. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 2.77%, the 86th percentile. No source names a fixed version.